| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/29/2004 | US20040018589 Induce immunology response; in situ proteolysis |
| 01/29/2004 | US20040018587 Nanostructures containing antibody assembly units |
| 01/29/2004 | US20040018586 Method for refolding proteins containing free cysteine residues |
| 01/29/2004 | US20040018569 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection |
| 01/29/2004 | US20040018547 Ion channel receptor and uses thereof |
| 01/29/2004 | US20040018536 Molecule for assigning genotype to phenotype and components thereof as well as method for constructing assigning molecule and method for utilizing assigning molecule |
| 01/29/2004 | US20040018534 Fused DNA sequence, fused protein expressed from said fused DNA sequence and method for expressing said fused protein |
| 01/29/2004 | US20040018514 Nucleotide sequence derived from Listeria inocua |
| 01/29/2004 | US20040018508 Surrogate antibodies and methods of preparation and use thereof |
| 01/29/2004 | US20040018198 Antibodies against carbonic anydrase IX (CA IX) tumor antigen |
| 01/29/2004 | US20040018196 Proteins and nucleic acids encoding same |
| 01/29/2004 | US20040018194 Administering proteins that bind to CD30, or compete with monoclonal antibodies AC10 or HeFi-1 for binding to CD30, and exert a cytostatic or cytotoxic effect on Hodgkin's disease cells in the absence of effector cells or complement |
| 01/29/2004 | US20040018191 Neutralizing human anti-IGFR antibody |
| 01/29/2004 | CA2493679A1 Methods for generating enhanced antibody-producing cell lines with improved growth characteristics |
| 01/29/2004 | CA2493258A1 Synthesis of oligosaccharides, glycolipids, and glycoproteins using bacterial clycosyltransferases |
| 01/29/2004 | CA2492905A1 Method of obtaining viable human liver cells, including hepatic stem/progenitor cells |
| 01/29/2004 | CA2492598A1 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 01/29/2004 | CA2492498A1 Flea and tick octopamine receptor nucleic acid molecules, proteins and uses thereof |
| 01/29/2004 | CA2492377A1 Recombinant production of mixtures of antibodies |
| 01/29/2004 | CA2487400A1 Methods of enhancing yields of soluble proteins |
| 01/29/2004 | CA2467691A1 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 01/28/2004 | EP1384778A1 Process for synthesizing protein using cell-free protein synthesis system |
| 01/28/2004 | EP1384726A2 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 01/28/2004 | EP1384075A1 Methods of detecting early renal disease in animals |
| 01/28/2004 | EP1383927A2 New polynucleotides and polypeptides of the erythropoietin gene |
| 01/28/2004 | EP1383907A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 01/28/2004 | EP1383895A2 Polynucleotides and polypeptides of the ifnalpha-5 gene |
| 01/28/2004 | EP1383893A2 Proteins and nucleic acids encoding same |
| 01/28/2004 | EP1383892A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/28/2004 | EP1383889A1 Modified organs and cells for xenotransplantation |
| 01/28/2004 | EP1383884A2 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon |
| 01/28/2004 | EP1383883A2 Asthma-associated snps around microsatellite marker d2s308 and identification of human prolyl-oligopeptidase-dpp10 |
| 01/28/2004 | EP1383882A2 Isolated human lipase proteins, nucleic acid molecules encoding human lipase proteins, and uses thereof |
| 01/28/2004 | EP1383801A1 Antibodies against cancer |
| 01/28/2004 | EP1383800A1 RECOMBINANT ANTIBODIES COEXPRESSED WITH GnTIII |
| 01/28/2004 | EP1383798A2 Transporters and ion channels |
| 01/28/2004 | EP1383789A2 Proteins associated with cell growth, differentiation, and death |
| 01/28/2004 | EP1383784A1 A hepatitis b virus surface antigen mutant and methods of detection thereof |
| 01/28/2004 | EP1383783A2 Leinamycin biosynthesis gene cluster and its components and their uses |
| 01/28/2004 | EP1383532A2 Combination therapy |
| 01/28/2004 | EP1383528A2 Epitope sequences |
| 01/28/2004 | EP1383393A2 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 01/28/2004 | EP1021528B1 Methods of refolding proteins by use of zwitterionic low molecular weight agents |
| 01/28/2004 | EP0973869B1 Method for increasing the growth of plant cell cultures |
| 01/28/2004 | EP0914345B1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2) |
| 01/28/2004 | EP0724597B1 Ks-laminin and methods of use |
| 01/28/2004 | EP0690675B1 Nucleic acid coding for a tumor rejection antigen precursor |
| 01/28/2004 | CN1471582A Methods for producing a polypeptide using a consensus translational initiator sequence |
| 01/28/2004 | CN1470640A Collagenic protein powder, and its preparing method and use |
| 01/28/2004 | CN1470635A Polypeptide-human protein tyrosine phosphatase 10 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470530A Humanmachine tumour monoclonal antibody, and its preparing method and use |
| 01/28/2004 | CN1470527A Polypeptide-human calcium ion regulatory secretory action protein 48 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470526A Polypeptide-human muscle BOP protein 41 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470525A Polypeptide-human SEH protein 29 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470524A Polypeptide-human transcriptional elongation factor IIS51 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470523A Polypeptide-zinc finger protein 64 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470522A Polypeptide-XRN-100 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470521A Polypeptide-mitochondrial carrier 12 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470520A Polypeptide-zine finger protein 40 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1136317C Process for preparing bisegmentum and monosegmentum of monoclone antibody |
| 01/27/2004 | US6683171 Contacting fkhsf specific nucleic acid probe under high stringency hybridizing conditions with at least one nucleic acid molecule from biological sample, detecting formation of hybrid, indicating presence of fkhsf nucleic acid molecule |
| 01/27/2004 | US6683170 Including peptides which selectively bound by targeted cell so that modified fiber protein is internalized by receptor-mediated endocytosis; trimerization |
| 01/27/2004 | US6683160 Antibodies specific for Fkhsf gene products |
| 01/27/2004 | US6683158 Alpha-subunit of the Mac-1 leukocyte adhesion receptor |
| 01/27/2004 | US6683088 Sulfonamido ether substituted imidazoquinolines |
| 01/27/2004 | US6683046 Purification and characterization of cytotoxic lymphocyte maturation factor and monoclonal antibodies thereto |
| 01/27/2004 | US6682910 Gene expression, incubation; genetic engineering |
| 01/27/2004 | US6682902 Human extracellular matrix polypeptides; polynucleotides; expression vectors; host cells; medical diagnosis; prostate cancer; detection of metastasis |
| 01/27/2004 | US6682901 Detecting cancer in humans; obtain cells, incubate with cadherins, monitor binding |
| 01/27/2004 | US6682743 Genetically engineered virus for use in the propagation of preferential cells |
| 01/27/2004 | US6682735 Anti-IgE antibodies |
| 01/27/2004 | US6682734 Anti-cd20 derived from transfectoma having atcc deposit numbers 69119 and hbe 1388 respectively; depletion of peripheral blood b cells |
| 01/27/2004 | CA2105644C Resurfacing of rodent antibodies |
| 01/27/2004 | CA2080428C A method for preparing a thromboplastin reagent from cultured cells that is suitable for use in the prothrombin time test |
| 01/27/2004 | CA2002607C Natural killer stimulatory factor |
| 01/22/2004 | WO2004008100A2 Methods and media for controlling sialylation of proteins produced by mammalian cells |
| 01/22/2004 | WO2004007740A1 Biological method for producing t-20 peptide |
| 01/22/2004 | WO2004007723A2 Genes |
| 01/22/2004 | WO2004007716A1 Method of isolating gpcr gene and novel gpcr gene |
| 01/22/2004 | WO2004007593A1 Poly-gamma-glutamate having ultra high molecular weight and method for using the same |
| 01/22/2004 | WO2004006955A1 Super humanized antibodies |
| 01/22/2004 | WO2004006840A2 Three dimensional cell patterned bioploymer scaffolds and method of making the same |
| 01/22/2004 | WO2004006756A2 THERAPIES FOR RENAL FAILURE USING INTERFERON-β |
| 01/22/2004 | WO2003102143A3 HUMAN COACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1 (hCARM1) |
| 01/22/2004 | WO2003066002A3 IFN-a/b-INDEPENDENT MECHANISM OF ANTIVIRAL PROTECTION |
| 01/22/2004 | WO2003054140A3 Phosphate limited inducible promoter and a bacillus expression system |
| 01/22/2004 | WO2003048303A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/22/2004 | WO2003048205A3 Novel proteins with il-6 inhibiting activity |
| 01/22/2004 | WO2002076389A3 Compositions and methods to prevent metastasis from primary malignancies |
| 01/22/2004 | WO2002069886A3 Modified proteins, designer toxins, and methods of making thereof |
| 01/22/2004 | US20040016023 Modification of plant cell wall component and method of regulating development differentiation |
| 01/22/2004 | US20040016007 The chimeric mice can be immunized over a long time and enable one to obtain human antibodies against arbitrary antigens containing a human self-component |
| 01/22/2004 | US20040014954 Comprises nucleotide sequences coding secreted polypeptides for diagnosing, preventing and treating autoimmune, cancer and transplant disorders; wound healing agents |
| 01/22/2004 | US20040014946 Using mass spectroscopy to identify, reconstitute and determine the kinetics of multimeric polypeptide complexes; drug screening |
| 01/22/2004 | US20040014942 Transformation cells by introduction of a false-sense mutation at a target codon of a gene coding for a protein necessary for the growth of the cells, such protein synthesized from the gene thus mutated is non functional |
| 01/22/2004 | US20040014668 Human NK3-related prostate specific gene 1 |
| 01/22/2004 | US20040014218 Dhfr-deficient cho cell line transfected with an anti-apoptotic gene, method for preparation thereof, and method for producing target protein using the same |
| 01/22/2004 | US20040014190 Stable plasminogen activator inhibitor for treatment of thrombosis and cardiovascular diseases |
| 01/22/2004 | US20040014178 Von willebrand factor-binding proteins from staphylococci |
| 01/22/2004 | US20040014177 Using leukemia cells as bioreactor for production of heterologous protein; gene therapy |